Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012

Summary

companys clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012 provides data on the Retinitis Pigmentosa (Retinitis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinitis Pigmentosa (Retinitis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinitis Pigmentosa (Retinitis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by companys team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 4
List of Figures 6
Introduction 7
Retinitis Pigmentosa (Retinitis) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Retinitis Pigmentosa (Retinitis) 24
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Neurotech Pharmaceuticals, Inc. 31
Clinical Trial Overview of Neurotech Pharmaceuticals, Inc. 31
R-Tech Ueno, Ltd. 32
Clinical Trial Overview of R-Tech Ueno, Ltd. 32
Okuvision GmbH 33
Clinical Trial Overview of Okuvision GmbH 33
Sucampo Pharmaceuticals, Inc. 34
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 34
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Daewoong Pharmaceutical Co., Ltd. 36
Clinical Trial Overview of Daewoong Pharmaceutical Co., Ltd. 36
Oxford BioMedica plc 37
Clinical Trial Overview of Oxford BioMedica plc 37
Isis Pharmaceuticals, Inc. 38
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 38
Allergan, Inc. 39
Clinical Trial Overview of Allergan, Inc. 39
Johnson & Johnson 40
Clinical Trial Overview of Johnson & Johnson 40
Clinical Trial Overview of Top Universities / Institutes / Hospitals 41
National Neurovision Research Institute 41
Clinical Trial Overview of National Neurovision Research Institute 41
Third Military Medical University 42
Clinical Trial Overview of Third Military Medical University 42
Kyushu University 43
Clinical Trial Overview of Kyushu University 43
Chiba University Hospital 44
Clinical Trial Overview of Chiba University Hospital 44
Nagoya City University Hospital 45
Clinical Trial Overview of Nagoya City University Hospital 45
Institute of Biomedical Research and Innovation Hospital 46
Clinical Trial Overview of Institute of Biomedical Research and Innovation Hospital 46
Montpellier University Hospital 47
Clinical Trial Overview of Montpellier University Hospital 47
Azienda Policlinico Umberto I 48
Clinical Trial Overview of Azienda Policlinico Umberto I 48
Tokyo Womens Medical University 49
Clinical Trial Overview of Tokyo Womens Medical University 49
Tehran University of Medical Sciences 50
Clinical Trial Overview of Tehran University of Medical Sciences 50
Semmelweis University 51
Clinical Trial Overview of Semmelweis University 51
Chiba University 52
Clinical Trial Overview of Chiba University 52
Osaka University 53
Clinical Trial Overview of Osaka University 53
Indian Council of Medical Research 54
Clinical Trial Overview of Indian Council of Medical Research 54
Seoul National University Hospital 55
Clinical Trial Overview of Seoul National University Hospital 55
Columbia University 56
Clinical Trial Overview of Columbia University 56
University of Sao Paulo 57
Clinical Trial Overview of University of Sao Paulo 57
Sheba Medical Center 58
Clinical Trial Overview of Sheba Medical Center 58
Johns Hopkins University 59
Clinical Trial Overview of Johns Hopkins University 59
University of California, San Francisco 60
Clinical Trial Overview of University of California, San Francisco 60
Five Key Clinical Profiles 61
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About company 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables

Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, G7 Countries, 2012* 17
Retinitis Pigmentosa (Retinitis) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, E7 Countries, 2012* 19
Retinitis Pigmentosa (Retinitis) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Terminated Clinical Trials, 2012* 24
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurotech Pharmaceuticals, Inc., 2012* 31
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by R-Tech Ueno, Ltd., 2012* 32
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Okuvision GmbH, 2012* 33
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2012* 34
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 35
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daewoong Pharmaceutical Co., Ltd., 2012* 36
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oxford BioMedica plc, 2012* 37
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2012* 38
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2012* 39
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 40
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Neurovision Research Institute, 2012* 41
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2012* 42
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2012* 43
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University Hospital, 2012* 44
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya City University Hospital, 2012* 45
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2012* 46
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2012* 47
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Policlinico Umberto I, 2012* 48
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Womens Medical University, 2012* 49
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2012* 50
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Semmelweis University, 2012* 51
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2012* 52
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2012* 53
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2012* 54
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 55
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012* 56
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 57
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012* 58
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 59
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 60

List of Figures

Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Retinitis Pigmentosa (Retinitis) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Retinitis Pigmentosa (Retinitis) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30
company Methodology 78